北京大学学报(医学版) ›› 2015, Vol. 47 ›› Issue (4): 661-666. doi: 10.3969/j.issn.1671-167X.2015.04.023

• 论著 • 上一篇    下一篇

肿瘤干细胞样细胞RNA致敏树突状细胞治疗大鼠9L脑肿瘤

肖宗宇1△,陈晓娟2,杨艺3,徐如祥3   

  1. (1.青海大学附属医院神经外科,西宁810000; 2. 青海省人民医院神经内科,西宁810000;3. 北京军区总医院附属八一脑科医院,北京100700)
  • 出版日期:2015-08-18 发布日期:2015-08-18
  • 通讯作者: 肖宗宇 E-mail:xiaozongyu@hotmail.com
  • 基金资助:

    青海大学中青年科研基金(2014-QYY-6)资助

Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors

XIAO Zong-yu1△, CHEN Xiao-juan2, YANG Yi3, XU Ru-xiang3   

  1. (1. Department of neurosurgery, Affiliated Hospital of Qinghai University, Xining 810000, China; 2. Department of Neurology, People’s Hospital of Qinghai Province, Xining 810000,China; 3. Affiliated Bayi Brain Hospital of Military General Hospital of Beijing PLA, Beijing 100700,China)
  • Online:2015-08-18 Published:2015-08-18
  • Contact: XIAO Zong-yu E-mail:xiaozongyu@hotmail.com
  • Supported by:

    Supported by Youth Foundation of Qinghai University (2014-QYY-6)

摘要:

目的:利用大鼠9L肿瘤干细胞样细胞(cancer stem like cells,CSLCs)总RNA致敏树突状细胞(dendritic cells,DC)治疗9L/F344大鼠颅内胶质瘤,观察DC疫苗对脑胶质瘤的治疗作用,探讨其免疫反应的机制,为DC疫苗的临床应用提供实验基础。方法:40只颅内荷瘤F344大鼠随机分成4组,每组10只,作为实验组:(1)树突状细胞组(DC-9L):注射转染贴壁9L细胞RNA的DC组;(2)DC-9LTS组:注射转染9L肿瘤球RNA的DC组;(3)DC组:注射未经转染RNA;(4)磷酸盐缓冲液(phosphate buffered saline,PBS)组:注射100 μL PBS。非荷瘤F344大鼠10只设为对照组,仅在右侧尾状核注射10 μL DMEM/F12培养基。利用大鼠9L肿瘤干细胞样细胞的总RNA致敏DC,制备DC-9LTS,采用皮下注射的方式,对9L/F344大鼠颅内胶质瘤模型进行免疫治疗,观察荷瘤大鼠生存期,同时检测血清干扰素-γ(interferon-gamma,IFN-γ)的浓度,免疫组织化学染色对各治疗组肿瘤组织CD4、CD8淋巴细胞浸润情况进行分析。结果:各实验组大鼠的中位生存期分别为:PBS组21 d,DC组为21 d,DC-9L组为31 d,DC9LTS组为36 d。DC-9LTS组大鼠的中位生存期与其余各组比较,差异有统计学意义(P<0.01);DC-9L组与DC组、PBS组比较,差异有统计学意义(P<0.01);而DC组与PBS组之间差异无统计学意义(χ2=0.071,P=0.789),DC-9LTS组的IFNγ浓度为(157.08±7.25) ng/L,高于其余各组(P<0.05),且大鼠肿瘤组织内部及瘤周组织均有大量CD8淋巴细胞浸润。DC-9L组中,在肿瘤组织内部及瘤周也可见CD8淋巴细胞浸润, DC-9LTS组CD8的平均光密度值(D)明显高于DC-9L组(P<0.001),DC-9LTS组及DC-9L组均未见CD4淋巴细胞的表达。在DC组和PBS组中,肿瘤组织中未见CD4或CD8淋巴细胞浸润。结论:利用大鼠9L肿瘤干细胞样细胞总RNA体外致敏树突状细胞,制备树突状细胞疫苗,回输治疗9L/F344大鼠颅内胶质瘤,能明显延长荷瘤大鼠生存期,为靶向性杀伤脑肿瘤干细胞的胶质瘤免疫治疗提供了实验基础及理论依据。

关键词: 脑肿瘤, 肿瘤干细胞, 树突细胞, 免疫疗法, 神经胶质瘤

Abstract:

Objective:To investigate the anti-tumor efficacy of dendritic cells (DC) vaccination transfected with total RNA of cancer stem like cells and to discuss the mechanism of immune response, so as to provide experimental basis for clinical application.Methods: Dendritic cells were isolated from F344 bone marrow cells, then these dendritic cells were transfected with total RNA of 9L cancer stem cells or 9L monolayer cells. F344 rats bearing with 9L brain tumors were treated by subcutaneous injection of either PBS, unpulsed DC, DC transfected with 9L monolayer cells RNA (DC-9LTS) or DC transfected with 9L tumor spheres RNA (DC-9L)3, 10, 17. And 21 days after tumor implantation, the brains and sera were obtained from the different groups, the lymphocytes infiltration was detected by immunohistochemistry, and the concentration of interferon-γ(IFN-γ) was tested by ELISA. The survival time was observed and determined using the method of Kaplan Meier analysis.Results: The rats vaccinated with DC transfected with 9L tumor spheres RNA (DC9LTS) and the monolayer cell RNA (DC-9L) expired with median survival time of 36 and 31 days, respectively. The animals bearing intracranial 9L gliosarcoma were vaccinated with unpulsed DC vaccine, all expired with a median survival time of 21 days. The Kaplan-Meier survival curve showed that the rats treated with DC-9LTS had longer survival than the other groups (P<0.01). There was significant difference among DC-9L group, DC group, and PBS group (P<0.01). There was no significant difference between DC group and PBS group (χ2=0.071, P=0.789).The concentration of IFNgamma of DC-9LTS group[(157.08±7.25) ng/L]was much higher than those of the other groups (P<0.05). DC-9LTS could effectively enhance T-cell infiltration, a large number of CD8+ cells were detected in and around the tumor in DC-9LTS group, compared with DC-9L group, DC and PBS group (P<0.001). The expression of CD8+ cell was not detected in DC group and PBS group. However no expression of CD4+ cells was observed in all the groups. Conclusion: Immunotherapy using DC transfected with 9L CSLCs total RNA was more effective for the treatment of 9L brain gliomas, and the strategy prolonged the survival of 9L glioma-bearing rats significantly, which provides a scientific foundation for further investigation of this approach to eradicate gliomas.

Key words: Brain neoplasms, Neoplastic stem cells, Dendritic cells, Immunotherapy, Glioma

中图分类号: 

  • R739.4
[1] 农琳,王微,梁丽,李东,李鑫,李挺. 母细胞性浆样树突细胞肿瘤13例临床病理学特征[J]. 北京大学学报(医学版), 2023, 55(2): 308-314.
[2] 任军,杨朵. 提高过继性T细胞免疫治疗临床疗效的新思考----肠道菌群与肿瘤免疫[J]. 北京大学学报(医学版), 2020, 52(2): 204-206.
[3] 王惠, 叶锦棠, 姚红新, 李东, 董颖. 婴儿胚胎发育不良性神经上皮肿瘤1例报道并文献复习[J]. 北京大学学报(医学版), 2017, 49(5): 904-909.
[4] 高阳旭,张宏武,沈笠雪,刘宝富,姚红新. 2例小儿颅内恶性肿瘤合并血友病A的围手术期处理[J]. 北京大学学报(医学版), 2015, 47(6): 1037-1038.
[5] 叶海云,许清泉,黄晓波,马凯,王晓峰. 卡介苗膀胱灌注治疗致结核性前列腺脓肿1例[J]. 北京大学学报(医学版), 2015, 47(6): 1039-1041.
[6] 王小利, 马博, 贾军, 袁艳华, 严颖, 邸立军, 宋国红, 余靖, 任军. rAAV/CEA转染树突状细胞诱导特异性CTL杀伤MCF-7细胞系CD44+CD24-/low乳腺癌干细胞[J]. 北京大学学报(医学版), 2011, 43(2): 173-178.
[7] 陈念平, 祝胜美, 叶青山, 蒋宗明, 楼静芝. 泮托拉唑在颅内肿瘤手术中的应用[J]. 北京大学学报(医学版), 2010, 42(2): 228-230.
[8] 王衣祥, 许振起, 刘宇, 李盛林. 联合应用非特异激活的免疫细胞和化疗药物顺铂治疗血管内皮瘤[J]. 北京大学学报(医学版), 2010, 42(2): 211-215.
[9] 曹宝山, 任军. 非小细胞肺癌干细胞研究进展[J]. 北京大学学报(医学版), 2008, 40(5): 555-555.
[10] 黄明主, 张凤春, 张雁云. 乳腺癌干细胞微球体形成的影响因素[J]. 北京大学学报(医学版), 2008, 40(5): 500-504.
[11] 马博, 任军, 姜晗昉, 贾军. 肿瘤源性外切体负载的间充质干细胞抗肿瘤活性的实验研究[J]. 北京大学学报(医学版), 2008, 40(5): 494-499.
[12] 贾军, 任军, 张红梅, 张利旺, 郭晓彤. 造血干细胞来源的树突状细胞负载p53基因诱导对HMCC97肝癌细胞特异性杀伤[J]. 北京大学学报(医学版), 2008, 40(5): 489-493.
[13] 邸立军, 任军, 宋国红, 余靖, 方健, 车利, 祝毓琳. 自体外周血CD34+干细胞来源树突状细胞体外扩增治疗恶性体腔积液[J]. 北京大学学报(医学版), 2008, 40(5): 486-488.
[14] 鲁智豪, 贾军, 任军, 马博, 邸立军, 宋国红. 乳腺癌干细胞的检测及Hedgehog信号通路关键分子的表达[J]. 北京大学学报(医学版), 2008, 40(5): 480-485.
[15] 孙晋敏, 张超, 李学农. 肿瘤干细胞表面标记物CD133高亲和结合肽的筛选[J]. 北京大学学报(医学版), 2008, 40(5): 476-479.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!